[HTML][HTML] High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints
MA Lisio, L Fu, A Goyeneche, Z Gao… - International journal of …, 2019 - mdpi.com
Among a litany of malignancies affecting the female reproductive tract, that of the ovary is the
most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled …
most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled …
Endometriosis and cancer: a systematic review and meta-analysis
M Kvaskoff, Y Mahamat-Saleh… - Human reproduction …, 2021 - academic.oup.com
BACKGROUND Endometriosis is an often chronic, inflammatory gynaecologic condition
affecting 190 million women worldwide. Studies have reported an elevated cancer risk …
affecting 190 million women worldwide. Studies have reported an elevated cancer risk …
[HTML][HTML] Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label …
Background Low-grade serous carcinoma of the ovary or peritoneum is characterised by
MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high …
MAPK pathway aberrations and its reduced sensitivity to chemotherapy relative to high …
An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity
O Kopper, CJ De Witte, K Lõhmussaar… - Nature medicine, 2019 - nature.com
Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage.
Experimental in vitro models that faithfully capture the hallmarks and tumor heterogeneity of …
Experimental in vitro models that faithfully capture the hallmarks and tumor heterogeneity of …
[HTML][HTML] PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer
Pharmacologic inhibition of PARP is the primary therapeutic strategy for BRCA mutant
ovarian cancer. However, most of patients carry wild-type BRCA1/2 with no significant …
ovarian cancer. However, most of patients carry wild-type BRCA1/2 with no significant …
GRP78: A cell's response to stress
Abstract Background Glucose-Regulated Protein 78 (GRP78) is a chaperone heat shock
protein that has been intensely studied in the last two decades. GRP78 is the master of the …
protein that has been intensely studied in the last two decades. GRP78 is the master of the …
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
LE Kandalaft, D Dangaj Laniti, G Coukos - Nature Reviews Cancer, 2022 - nature.com
Abstract Treatment of high-grade serous ovarian cancer (HGSOC) remains challenging.
Although HGSOC can potentially be responsive to immunotherapy owing to endogenous …
Although HGSOC can potentially be responsive to immunotherapy owing to endogenous …
[HTML][HTML] Recent insights into PARP and immuno-checkpoint inhibitors in epithelial ovarian cancer
A Revythis, A Limbu, C Mikropoulos, A Ghose… - International journal of …, 2022 - mdpi.com
Ovarian cancer is one of the most common gynecologic cancers and has the highest
mortality rate of any other cancer of the female reproductive system. Epithelial ovarian …
mortality rate of any other cancer of the female reproductive system. Epithelial ovarian …
Endometriosis: epidemiology, diagnosis and clinical management
Abstract Purpose of Review Endometriosis is a disease of adolescents and reproductive-
aged women characterized by the presence of endometrial tissue outside the uterine cavity …
aged women characterized by the presence of endometrial tissue outside the uterine cavity …
[HTML][HTML] Epithelial ovarian cancer: providing evidence of predisposition genes
S Shah, A Cheung, M Kutka, M Sheriff… - International Journal of …, 2022 - mdpi.com
Epithelial ovarian cancer (EOC) is one of the cancers most influenced by hereditary factors.
A fourth to a fifth of unselected EOC patients carry pathogenic variants (PVs) in a number of …
A fourth to a fifth of unselected EOC patients carry pathogenic variants (PVs) in a number of …